Girija Regmi

Dr. Girija Regmi


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2019 in Blood Advances
Verified
Journal Article
Open access
PDF file
RSRobert Silasi
Robert Silasi
RKRavi Shankar Keshari
Ravi Shankar Keshari
CLCristina Lupu
Cristina Lupu
WRWalter Janse Van Rensburg
Walter Janse Van Rensburg
HCHala Chaaban
Hala Chaaban
FLFlorea Lupu
Florea Lupu
Staphylococcus aureus infections can produce systemic bacteremia and inflammation in humans, which may progress to severe sepsis or septic shock, even with appropriate antibiotic treatment. Sepsis may be associated with disseminated intravascular coagulation and consumptive coagulopathy. In some types of mouse infection models, the plasma coagulation protein factor XI (FXI) contributes to the pathogenesis of sepsis. We hypothesize that FXI also contributes to the pathogenesis of sepsis in primates, and that pharmacological interference with FXI will alter the outcome of Staphylococcus aureus–induced lethality in a baboon model. Pretreatment of baboons with the anti-FXI antibody 3G3, a humanized variant of the murine monoclonal 14E11 that blocks FXI activation by FXIIa, substantially reduced the activation of coagulation, as reflected by clotting times and plasma complexes of coagulation proteases (FXIIa, FXIa, FIXa, FXa, FVIIa, and thrombin) with serpins (antithrombin or C1 inhibitor) following infusion of heat-inactivated S aureus. 3G3 treatment reduced fibrinogen and platelet consumption, fibrin deposition in tissues, neutrophil activation and accumulation in tissues, cytokine production, kininogen cleavage, cell death, and complement activation. Overall, 3G3 infusion protected the structure and function of multiple vital organs, including lung, heart, liver, and kidney. All treated animals reached the end point survival (7 days), whereas all nontreated animals developed terminal organ failure within 28 hours. We conclude that FXI plays a role in the pathogenesis of S aureus–induced disseminated intravascular coagulation and lethality in baboons. The results provide proof of concept for future therapeutic interventions that may prevent sepsis-induced organ failure and save lives in certain forms of sepsis.

27 February 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
HCHala Chaaban
Hala Chaaban
MPMaulin Patel
Maulin Patel
KBKathryn Burge
Kathryn Burge
JEJeffrey Eckert
Jeffrey Eckert
CLCristina Lupu
Cristina Lupu
FLFlorea Lupu
Florea Lupu
Increasing evidence suggests that prolonged antibiotic therapy in preterm infants is associated with increased mortality and morbidities, such as necrotizing enterocolitis (NEC), a devastating gastrointestinal pathology characterized by intestinal inflammation and necrosis. While a clinical correlation exists between antibiotic use and the development of NEC, the potential causality of antibiotics in NEC development has not yet been demonstrated. Here, we tested the effects of systemic standard-of-care antibiotic therapy for ten days on intestinal development in neonatal mice. Systemic antibiotic treatment impaired the intestinal development by reducing intestinal cell proliferation, villi height, crypt depth, and goblet and Paneth cell numbers. Oral bacterial challenge in pups who received antibiotics resulted in NEC-like intestinal injury in more than half the pups, likely due to a reduction in mucous-producing cells affecting microbial–epithelial interactions. These data support a novel mechanism that could explain why preterm infants exposed to prolonged antibiotics after birth have a higher incidence of NEC and other gastrointestinal disorders.

17 February 2021 in Blood
Verified
Journal Article
Open access
PDF file
RSRobert Silasi
Robert Silasi
RKRavi S. Keshari
Ravi S. Keshari
GRGirija Regmi
Girija Regmi
CLCristina Lupu
Cristina Lupu
CGConstantin Georgescu
Constantin Georgescu
FLFlorea Lupu
Florea Lupu
Activation of coagulation factor (F) XI promotes multiorgan failure in rodent models of sepsis and in a baboon model of lethal systemic inflammation induced by infusion of heat-inactivated Staphylococcus aureus. Here we used the anticoagulant FXII-neutralizing antibody 5C12 to verify the mechanistic role of FXII in this baboon model. Compared with untreated control animals, repeated 5C12 administration before and at 8 and 24 hours after bacterial challenge prevented the dramatic increase in circulating complexes of contact system enzymes FXIIa, FXIa, and kallikrein with antithrombin or C1 inhibitor, and prevented cleavage and consumption of high-molecular-weight kininogen. Activation of several coagulation factors and fibrinolytic enzymes was also prevented. D-dimer levels exhibited a profound increase in the untreated animals but not in the treated animals. The antibody also blocked the increase in plasma biomarkers of inflammation and cell damage, including tumor necrosis factor, interleukin (IL)-1β, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor, nucleosomes, and myeloperoxidase. Based on clinical presentation and circulating biomarkers, inhibition of FXII prevented fever, terminal hypotension, respiratory distress, and multiorgan failure. All animals receiving 5C12 had milder and transient clinical symptoms and were asymptomatic at day 7, whereas untreated control animals suffered irreversible multiorgan failure and had to be euthanized within 2 days after the bacterial challenge. This study confirms and extends our previous finding that at least 2 enzymes of the contact activation complex, FXIa and FXIIa, play critical roles in the development of an acute and terminal inflammatory response in baboons challenged with heat-inactivated S aureus.

10 November 2020 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
RKRavi S. Keshari
Ravi S. Keshari
RSRobert Silasi
Robert Silasi
NPNarcis I. Popescu
Narcis I. Popescu
GRGirija Regmi
Girija Regmi
HCHala Chaaban
Hala Chaaban
FLFlorea Lupu
Florea Lupu

10 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RKRavi Shankar Keshari
Ravi Shankar Keshari
NPNarcis I. Popescu
Narcis I. Popescu
RSRobert Silasi
Robert Silasi
GRGirija Regmi
Girija Regmi
CLCristina Lupu
Cristina Lupu
FLFlorea Lupu
Florea Lupu
Late-stage anthrax infections are characterized by dysregulated immune responses and hematogenous spread of Bacillus anthracis, leading to extreme bacteremia, sepsis, multiple organ failure, and, ultimately, death. Despite the bacterium being nonhemolytic, some fulminant anthrax patients develop a secondary atypical hemolytic uremic syndrome (aHUS) through unknown mechanisms. We recapitulated the pathology in baboons challenged with cell wall peptidoglycan (PGN), a polymeric, pathogen-associated molecular pattern responsible for the hemostatic dysregulation in anthrax sepsis. Similar to aHUS anthrax patients, PGN induces an initial hematocrit elevation followed by progressive hemolytic anemia and associated renal failure. Etiologically, PGN induces erythrolysis through direct excessive activation of all three complement pathways. Blunting terminal complement activation with a C5 neutralizing peptide prevented the progressive deposition of membrane attack complexes on red blood cells (RBC) and subsequent intravascular hemolysis, heme cytotoxicity, and acute kidney injury. Importantly, C5 neutralization did not prevent immune recognition of PGN and shifted the systemic inflammatory responses, consistent with improved survival in sepsis. Whereas PGN-induced hemostatic dysregulation was unchanged, C5 inhibition augmented fibrinolysis and improved the thromboischemic resolution. Overall, our study identifies PGN-driven complement activation as the pathologic mechanism underlying hemolytic anemia in anthrax and likely other gram-positive infections in which PGN is abundantly represented. Neutralization of terminal complement reactions reduces the hemolytic uremic pathology induced by PGN and could alleviate heme cytotoxicity and its associated kidney failure in gram-positive infections. Significance Late-stage anthrax leads to sepsis, characterized by uncontrolled host responses that contribute to organ damage and death. Using a nonhuman primate model, we demonstrate that bacterial wall peptidoglycan is the major trigger of complement activation. Terminal complement activation products promote secondary hemolytic uremic syndrome (HUS), characterized by hemolytic anemia, toxic accumulation of iron in the kidneys, and subsequent acute renal injury. Inhibition of C5 cleavage and subsequent formation of the lytic terminal complex C5b-9 prevented intravascular hemolysis and heme cytotoxicity and protected against peptidoglycan-induced acute kidney failure. Overall, treatment with C5 inhibitor significantly improved the survival of baboons with sepsis, suggesting a potentially important strategy to treat HUS secondary to gram-positive bacterial infections.

12 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
HCHala Chaaban
Hala Chaaban
KBKathryn Burge
Kathryn Burge
JEJeffrey Eckert
Jeffrey Eckert
MTMajoi Trammell
Majoi Trammell
DDDavid Dyer
David Dyer
FLFlorea Lupu
Florea Lupu
The beneficial effects of human milk suppressing the development of intestinal pathologies such as necrotizing enterocolitis in preterm infants are widely known. Human milk (HM) is rich in a multitude of bioactive factors that play major roles in promoting postnatal maturation, differentiation, and the development of the microbiome. Previous studies showed that HM is rich in hyaluronan (HA) especially in colostrum and early milk. This study aims to determine the role of HA 35 KDa, a HM HA mimic, on intestinal proliferation, differentiation, and the development of the intestinal microbiome. We show that oral HA 35 KDa supplementation for 7 days in mouse pups leads to increased villus length and crypt depth, and increased goblet and Paneth cells, compared to controls. We also show that HA 35 KDa leads to an increased predominance of Clostridiales Ruminococcaceae, Lactobacillales Lactobacillaceae, and Clostridiales Lachnospiraceae. In seeking the mechanisms involved in the changes, bulk RNA seq was performed on samples from the terminal ileum and identified upregulation in several genes essential for cellular growth, proliferation, and survival. Taken together, this study shows that HA 35 KDa supplemented to mouse pups promotes intestinal epithelial cell proliferation, as well as the development of Paneth cells and goblet cell subsets. HA 35 KDa also impacted the intestinal microbiota; the implications of these responses need to be determined.